SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ProMetic Life Sciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: axial2/20/2018 7:12:48 AM
   of 250
 
IAIP UPDATE

— This is NOT a verbatim reply from Prometic. It's paraphrased by eric40.

Jim
_______________________________________________

'I asked a couple of questions to Fred about IAIP. Here is a resume of it.

Prometic can already extract IAIP from Plasma with PPPS. I mean, the resin is ready and fully functional for the PPPS process. As for plasminogen, Prometic will probably be the only one in the world to be able to extract IAIP in commercial quantity with PPPS.

The partnership with Prothera from November, 19, 2015 excluded two orphan indications with IAIP and NEC is one of the two. So Prometic owned 100% of the profits from IAIP for NEC including also 100% of the very possible pediatric voucher. They expect the IND for IAIP for NEC to be in 2019. It will probably have a fast track designation according to Fred.

The clinical trial will consist in bringing the normal level of IAIP for the premature baby affected with NEC. Basically, they will mesure the level of IAIP of the premature baby with NEC then inject IAIP IV in order to bring and keep the normal level of IAIP in order to cure NEC. So it will be a very similar procedure as Pg clinical trial.

But with IAIP for NEC, the market is much bigger than PgCD and the Pediatric Voucher is probably 100% considering that the patients are premature baby and NEC is highly lifetreatening. Still a couple of years but great pipeline.'
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News